Position in ESPR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
29,228
-90.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $154,257,402 across 47 Drug Manufacturers - Specialty & Generic names. ESPR ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
368,249 | $26,462,373 | |
| 2 | HLN |
Haleon plc
|
2,036,156 | $18,997,335 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,431,267 | $14,870,864 | |
| 4 | VTRS |
Viatris Inc
|
678,057 | $10,767,545 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
432,525 | $10,644,440 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
62,420 | $10,520,266 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
258,667 | $8,967,984 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
555,228 | $8,900,304 |
All Filings in ESPR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 29,228 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | — | 292,267 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | — | 29,310 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | — | 27,634 | Shares | Sole | 2025-11-12 | |
| 2024-09-30 | — | 13,548 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | — | 17,548 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||